You are here: Industry Insights > gene therapy

News List

Recent Progress of Pharmaceutical Industry Lin Zhang
November 22, 2021
2021 has been a wild year for the world, and the pharmaceutical industry as well. There have been significant developments in the past few months that have changed the state of the industry...
iotaSciences Launches New isoPick™ Single-Cell Picker to Further Expand Handling Solutions for Efficient Cell Biology & Gene Therapy Applications PharmaSources
February 07, 2023
First isoPick™ showcases at upcoming ELRIG CRISPR IN DRUG DISCOVERY 2023 event in Oxford (UK) and SLAS 2023 meeting in San Diego (USA).
Gene genies: Oxford Biomedica and Homology Medicines create AAV business pharmatimes
January 28, 2022
Leading gene and cell therapy group, Oxford Biomedica, and Homology Medicines, have announced that the companies will establish...
Schreiner MediPharm Develops Freeze-Lock Cryo Label contractpharma
January 27, 2022
Withstands the sub-zero storage and transport temperatures needed for many cell and gene therapy medications or clinical trials.
Sharp Expands Gene Therapy Packaging Capabilities contractpharma
January 26, 2022
Invests in new gene therapy packaging and distribution capacity at EU Heerenveen facility.
Ori Biotech Expands Cell and Gene Therapy Manufacturing Capabilities contractpharma
January 24, 2022
Raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform.
Neurophth Therapeutics Receives IND Clearance to Initiate Clinical Trial for China AAV-ND4 Gene Therapy NR082 in Leber Hereditary Optic Neuropathy prnasia
January 20, 2022
Neurophth Therapeutics, Inc., (hereinafter referred to as "Neurophth"), today announced receiving the U.S. Food and Drug Administration (FDA) clearance of its investigational new drug (IND) application...
CBM and Penn Strike $100M Cell & Gene Therapy Deal contractpharma
January 20, 2022
Penn’s innovation in process science combines with CBM manufacturing capability..
Novartis to acquire UK’s Gyroscope Therapeutics for up to $1.5bn Pharmaceutical-Technology
December 24, 2021
Novartis has signed a definitive agreement for the acquisition of all the outstanding shares of UK’s ocular gene therapy firm Gyroscope Therapeutics, in a deal worth up to $1.5bn.
EMA Grants Accelerated Assessment for CSL Behring's Hemophilia B Gene Therapy AmericanPharmaceuticalReview
December 16, 2021
CSL Behring announced that the European Medicines Agency (EMA) has granted its approval for an accelerated assessment request for etranacogene dezaparvovec Marketing Authorization Application (MAA). Etranacogene dezaparvovec is an investigational gene...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page